Reversal of neuroinflammation in novel GS model mice by single i.c.v. administration of CHO-derived rhCTSA precursor protein-Reference-Cited by-同舟云学术

Reversal of neuroinflammation in novel GS model mice by single i.c.v. administration of CHO-derived rhCTSA precursor protein

Published:2022-06 Issue: Volume:25 Page:297-310
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Horii Yuto,Iniwa Toshiki,Onitsuka Masayoshi,Tsukimoto Jun,Tanaka Yuki,Ike Hironobu,Fukushi Yuri,Ando Haruna,Takeuchi Yoshie,Nishioka So-ichiro,Tsuji Daisuke,Ikuo Mariko,Yamazaki Naoshi,Takiguchi Yoshiharu,Ishimaru Naozumi,Itoh Kohji

Funder

Japan Society for the Promotion of Science

Ministry of Education, Culture, Sports, Science and Technology

Ministry of Agriculture, Forestry and Fisheries

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference47 articles.

1. Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man;d’Azzo;Proc. Natl. Acad. Sci. U S A,1982

2. Expression of cDNA encoding the human “protective protein” associated with lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases;Galjart;Cell,1988

3. Structure of the murine lysosomal multienzyme complex core;Gorelik;Sci. Adv.,2021

4. A peptidase in human platelets that deamidates tachykinins. Probable identity with the lysosomal “protective protein”;Jackman;J. Biol. Chem.,1990

5. Purification and characterization of human lysosomal protective protein expressed in stably transformed Chinese hamster ovary cells;Itoh;J. Biol. Chem.,1993

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Creation of an in vitro model of GM1 gangliosidosis by CRISPR/Cas9 knocking‐out the GLB1 gene in SH‐SY5Y human neuronal cell line;Cell Biochemistry and Function;2024-07-30

2. Neuraminidase-1 (NEU1): Biological Roles and Therapeutic Relevance in Human Disease;Current Issues in Molecular Biology;2024-07-26

3. Lysosomal sialidase NEU1, its intracellular properties, deficiency, and use as a therapeutic agent;Glycoconjugate Journal;2023-12

4. Human Neuraminidase 1 and Related Diseases;Trends in Glycoscience and Glycotechnology;2023-07-25

5. Structure of the immunoregulatory sialidase NEU1;Science Advances;2023-05-19